Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2025 | Story André Damons | Photo Supplied
Prof Wynand Goosen
Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards.

Being nominated for a ‘Science Oscar’ is exciting and validates nominees’ efforts, particularly in a field as challenging and essential as infectious diseases, for which they are recognised at the highest level. 

This is according to Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State (UFS). He was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards for his landmark discovery of Mycobacterium bovis infection in humans in South Africa – the first confirmed cases in the country. 

Prof Goosen, who previously won the NSTF-South32 Emerging Researcher Award, says the nomination is a powerful affirmation of the impact that focused, interdisciplinary research can have. It reflects not only his personal commitment but also the dedication of a talented and hard-working team. “I am honoured and humbled to be nominated. It is also a testament to the support and vision of UFS, particularly as we position ourselves as leaders in One Health research in South Africa,” he says. 

 

Focus of research 

He was nominated by Prof Vasu Reddy, UFS Deputy Vice-Chancellor: Research and Internationalisation, and Prof Paul Oberholster, Dean for the Faculty of Natural and Agricultural Sciences (NAS) at the UFS, and Prof Nico Gey van Pittius and Prof Elmi Muller from Stellenbosch University (US). The NSTF Awards, known as the ‘Science Oscars’of SA, honour, reward, celebrate, profile and promote outstanding contributions to science, engineering and technology (SET) and innovation in South Africa.

“The nomination,” Prof Goosen continues, “recognises our work in the field of zoonotic tuberculosis (TB) and other emerging infectious diseases at the human-animal-environment interface. Our research focuses on the molecular detection and characterisation of pathogenic mycobacteria in wildlife, livestock, and human populations, with the aim of informing better surveillance, diagnostics, and control strategies — particularly in high-risk ecosystems. This includes novel applications in wildlife TB surveillance and understanding the transmission dynamics between animals and people.”

 

Establishing a Kovsie One Health Research Unit

This research is critically important as South Africa continues to face a high burden of tuberculosis, including zoonotic TB, which often goes under-detected in rural and wildlife-rich areas. Understanding how these pathogens circulate between humans, animals, and the environment, explains Prof Goosen, is essential for effective disease control and to mitigate future pandemics. This work directly supports national health priorities, informs policy, and contributes to global strategies for One Health.

Prof Goosen and the team are in the process of laying the groundwork for the establishment of a Kovsie One Health Research Unit, which will serve as a collaborative platform for research spanning human, animal, and environmental health. One of their key projects involves expanding TB and AMR surveillance in wildlife-livestock-human interfaces, using cutting-edge diagnostics and genomic tools. They are also initiating partnerships with industry and international institutions to address emerging zoonoses and environmental pathogens in a transdisciplinary manner.

News Archive

We show our colours in support of autism awareness
2012-04-11

The Main Building on our Bloemfontein Campus will be illuminated in blue till the end of April to show support for autism awareness.
Photo: René-Jean van der Berg
12 April 2012

The Main Building on our Bloemfontein Campus will be illuminated in blue till the end of April to show our support for autism awareness, together with the rest of the world.

April is Autism Awareness Month and various iconic landmarks worldwide will be lit up in blue to honour those with autism.

Autism is one of only three conditions that are commemorated by the World Health Organisation.

Autism is a neurological condition that can be diagnosed in children as young as three years old. Worldwide one out of every 100 children is diagnosed within the autistic spectrum. This means that in South Africa a child is born with autism every hour and in the Free State some 400 children per year are born with the condition.

“Despite the high prevalence of autism in South Africa, South Africans know very little about it,” says Dr. David Griessel, an autism expert of the UFS’s Department of Paediatrics and Child Health. “Stories and films that attempt to portray autistic characters often create the wrong impression among the public concerning this complex illness. This distorts the reality since every child with autism is unique,” says Dr. Griessel.

He says it is important that all children with signs of autism are referred for evaluation as early intervention can prevent autism from further disrupting normal development.

Therapists and teachers who specialise in autism-specific treatment play an important role in this regard.

“However, there are no well-established services for toddlers in the Free State. Fortunately, there are classes developing in schools such as Lettie Fouché, Willem Postma and Pholoho, as well as in Kroonstad and Welkom. The Free State Autism Association has established a private school that offers a service to seven learners.”

For more information on autism in children or for information on special projects in the Free State, contact Dr. Griessel at +27(0)51 405 53177 or +27(0)51 405 3181.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept